Article Details
Retrieved on: 2024-09-14 05:24:04
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
(NASDAQ: HALO) ( Halozyme ) today announced that Roche received U.S. Food and Drug Administration (FDA) approval for OCREVUS ZUNOVO™ (ocrelizumab and ...
Article found on: markets.ft.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here